Clinical Trials Directory

Trials / Conditions / Pneumococcal Infectious Disease

Pneumococcal Infectious Disease

11 registered clinical trials studyying Pneumococcal Infectious Disease — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingClinical Trial of PCV24 in Infants and Children Aged 2 Months to 5 Years
NCT07300644
Sinovac Life Sciences Co., Ltd.Phase 2
RecruitingPCV24 Clinical Trial in Infants and Young Children Aged 2 Months (Minimum 6 Weeks) to 71 Months
NCT07333352
Shanghai Reinovax Biologics Co.,LTDPhase 2
RecruitingClinical Trial of PCV24 in Infants Aged 2-23 Months
NCT06800261
Sinovac Life Sciences Co., Ltd.Phase 1
RecruitingClinical Trial of 13-Valent Pneumococcal Conjugate Vaccine
NCT06617715
Sinovac Life Sciences Co., Ltd.Phase 3
CompletedClinical Trial of PCV24 in Children Aged 2-17 Years
NCT06550830
Sinovac Life Sciences Co., Ltd.Phase 1
CompletedClinical Trial of PCV24 in Adults
NCT06474377
Sinovac Life Sciences Co., Ltd.Phase 1
Active Not RecruitingPhase I Clinical Trial of PCV24 in Children Aged 2 Months (Minimum 6 Weeks) to 17 Years
NCT06675032
Shanghai Reinovax Biologics Co.,LTDPhase 1
Active Not RecruitingPhase II Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine
NCT06678620
Shanghai Reinovax Biologics Co.,LTDPhase 2
CompletedA Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine
NCT06183216
Sinovac Research and Development Co., Ltd.Phase 1
CompletedPhase I Clinical Trial of PCV24 in People Aged 18 Years and Older
NCT06678607
Shanghai Reinovax Biologics Co.,LTDPhase 1
CompletedA Clinical Trial to Observe the Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Target Population
NCT07071701
Sinovac Biotech Co., Ltd—